Some things are best left observed and not mentioned.
MVPs foray into Europe bears fruit with first firm orders received and delivery planned for January 2016.
"Galen is planning to launch Penthrox in December 2015 and we have received our first firm orders totalling almost $0.9 million. We have commenced manufacturing and expect to deliver these first orders commencing in January 2016. In addition Galen has submitted additional forecast orders for delivery in H2FY16 totaling in excess of $1.3 million.”
With growth predicted in respiratory product lines, Penthrox milestone payments and sales growth of Penthrox an EPS of 20 to 30 cents for FY2016 is a possibility. Taking the EPS midpoint and a share price of $4 PEis 16. Undervalued at $4.
DYOR.
Value of MVP, page-6
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.030(6.67%) |
Mkt cap ! $47.31M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 42.0¢ | $60.87K | 141.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 764 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 11858 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| MVP (ASX) Chart |